@scott_m_powell Scott, just my 2 cents, as a responsible OG investor let’s never broadcast our gains, it always signals market top and tumbles the stock ! I believe the worst is behind us and we will see good days ahead!
@bluefinsashimi@ImmunityBio This is very bullish news. A production capacity of 400 vials per minute suggests they are planning for multiple indications and global adoption. I hope that becomes a reality because it would be a win win for both patients and investors.
@SecKennedy@DrOzCMS You don’t have to look any further than @ImmunityBio and @DrPatrick. If the intent is genuinely to help, then work with Dr. Patrick and get things moving.
@thekookreport@techinvestoor He knows SpaceMob is a strong community backed by data and facts. That’s why he’s trying to cast doubt on its core pillars. We’ve seen many like him come and go. I have confidence in Kook because he’s always been fair in his views.
@Akashi1459455@themovecity@hb_lon They all need their initial beachhead or foothold with a MNO to iron out their tech, Starlink got it with T-mobile and I am sure Amazon wants it too.
@themovecity@hb_lon MNOs will provide spectrum and support to operators building D2D. Alongside ASTS, Amazon is also likely to be involved despite lacking D2D at the outset. Expect one or two surprise names. MNOs want to stay in control.
@QuinnHaze@hb_lon IMO the real purpose of this JV is to give MNOs a credible alternative to Starlink. They want a strong satellite brand, and right now Amazon fits that role. I believe ASTS will succeed regardless & will carry the D2D burden of this JV into 2030’s
@themovecity@hb_lon Starlink definitely triggered it but US MNO’s don’t want any single Satellite operator to be powerful enough to challenge their dominance. These guys are no saint!